跳至主要内容
临床试验/NCT04462068
NCT04462068已完成不适用

ACE and HLA Genotypes Predict Severity and Disease Progression in Danish Sarcoid Patients

University of Aarhus1 个研究点 分布在 1 个国家目标入组 150 人开始时间: 2019年12月1日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
150
试验地点
1
主要终点
Time to initiation of treatment

研究概览

简要总结

Sarcoidosis is a multisystem granulomatous disease of unknown cause histologically characterized by noncaseating granulomas. Genetic factors affect disease course, which is highly variable and difficult to predict.

This study aims to evaluate the predictive value of ACE and HLA genotypes on disease severity and progression in Danish patients with sarcoidosis.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Diagnosis of sarcoidosis
  • Signed informed consent

排除标准

  • Inability or unwillingness to adhere to the study
  • Inability to give informed consent

结局指标

主要结局

Time to initiation of treatment

时间窗: 1 year from diagnosis

Time to initiation of systemic immunosuppression for sarcoidosis

次要结局

  • Change in FEV1(1 year)
  • Number of participants with extrapulmonary organ involvement(1 year from diagnosis)
  • Change in diffusion capacity(1 year)
  • Change in FVC(1 year)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验